Craig Ulrick
Technik-/Wissenschafts-/F&E-Leiter bei TELIX PHARMACEUTICALS LIMITED
Aktive Positionen von Craig Ulrick
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Craig Ulrick
Ehemalige bekannte Positionen von Craig Ulrick
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACUMENTIS GROUP LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2018 | 01.06.2022 |
| SIRTEX MEDICAL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 | 01.06.2018 |
Ausbildung von Craig Ulrick
| Australian Catholic University | Undergraduate Degree |
Statistik
International
| Australien | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACUMENTIS GROUP LIMITED | Finance |
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sirtex Medical Pty Ltd.
 Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Sirtex Medical Ltd. manufactures, and distributes liver cancer treatments. It operates through the following geographical segments: Asia Pacific, Americas, and Europe, Middle East, and Africa. It offers targeted radiation therapy known as SIR Spheres Y-90 resin microspheres. The company was founded in 1997 and is headquartered in St Leonards, Australia. | Commercial Services |
- Börse
- Insiders
- Craig Ulrick
- Erfahrung
